ArticleFrontiers in cardiovascular medicine2026

miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytes.

Heidi Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.